Literature DB >> 11527065

The effectiveness of Tsu-San-Li (St-36) and Tai-Chung (Li-3) acupoints for treatment of acute liver damage in rats.

H J Liu1, S F Hsu, C C Hsieh, T Y Ho, C L Hsieh, C C Tsai, J G Lin.   

Abstract

This study investigated the effects of acupuncture on carbon tetrachloride (CCl4) induced acute liver injury in male rats (n=36). The experimental groups were injected with CCl4 before, during, or after acupuncture therapy. Acupoints similar to the human Tsu-San-Li (St-36) and Tai-Chung (Li-3) were needled bilaterally. Rats treated with CCl4 had higher levels of serum glutamate-oxalate-transaminase (sGOT) and serum glutamate-pyruvate-transaminase (sGPT). Comparing the experimental groups, biochemical and pathological parameters of liver injury were significantly reduced when rats were acupunctured after, not before, CCl4-induced hepatotoxicity. Acupuncture at the Tsu-San-Li and Tai-Chung acupoints cannot prevent acute liver injury but may be effective in treating liver injury induced by carbon tetrachloride in rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11527065     DOI: 10.1142/S0192415X01000253

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  3 in total

1.  Hepatoprotective effect of manual acupuncture at acupoint GB34 against CCl4-induced chronic liver damage in rats.

Authors:  Yun-Kyoung Yim; Hyun Lee; Kwon-Eui Hong; Young-Il Kim; Byung-Ryul Lee; Tae-Han Kim; Ji-Young Yi
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

2.  Recovery from hepatitis A after Korean medicine-based treatment : a case report.

Authors:  Chan-Ran Park; Gayoung Lee; Chang-Gue Son; Jung-Hyo Cho; Nam-Hun Lee
Journal:  Integr Med Res       Date:  2019-11-07

3.  Positive Effects of Laser Acupuncture in Methamphetamine Users Undergoing Group Cognitive Behavioral Therapy: A Pilot Study.

Authors:  Yi-Hsien Shiao; Yi-Chih Chen; Yuan-Chieh Yeh; Tse-Hung Huang
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-22       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.